Advertisement
News
Subscribe to MDT Magazine News

Harvard Bioscience 4Q profit falls on costs

February 25, 2011 8:45 am | by The Associated Press | Comments

Medical instruments maker Harvard Bioscience Inc. on Friday reported a dip in fourth-quarter net income despite higher revenues as its costs rose.The company earned $2.2 million, or 8 cents per share, down from profit of $3.8 million, or 12 cents per share, during the same period a year prior....

Community Health 4Q profit climbs nearly 7 percent

February 25, 2011 7:45 am | by The Associated Press | Comments

Shares of Community Health Systems Inc. jumped Friday, a day after the hospital operator said its fourth-quarter earnings grew nearly 7 percent, as revenue rose even though admissions at hospitals the company operated for at least a year fell.The Franklin company earned $69.5 million, or 76...

Viral infection not responsible for exacerbation of lung disease in most patients

February 25, 2011 7:39 am | by EurekAlert | Comments

(American Thoracic Society) Acute viral infection does not appear to be a primary cause of acute exacerbation of idiopathic pulmonary fibrosis, a progressive, deadly disease resulting in thickening and scarring of the lungs, according to a study conducted by researchers from the...

TOPICS:
Advertisement

New way to identify patients at risk of dysphagia after head and neck cancer treatment

February 25, 2011 7:39 am | by EurekAlert | Comments

(European Society for Medical Oncology) At the 3rd International Conference on innovative approaches in Head and Neck Oncology, Dr. Hanna Rahbek Mortensen and colleagues at hospitals and institutes in Denmark presented results from a large prospective trial, the DAHANCA 6 & 7...

TOPICS:

Little historical evidence to support cutting global health aid during recessions

February 25, 2011 7:39 am | by EurekAlert | Comments

(Harvard School of Public Health) According to a new study from the Harvard School of Public Health, there is surprisingly little historical evidence to justify reversing global financial aid commitments.

TOPICS:

ERT to Present at the Citi 2011 Global Health Care Conference on March 2, 2011

February 25, 2011 7:34 am | by Bio-Medicine.Org | Comments

PHILADELPHIA, Feb. 25, 2011 /- ERT (Nasdaq: ERES ), announced today that Dr. Joel Morganroth, the Company's Chairman and CEO, and Keith Schneck, the Company's Chief Financial Officer, are scheduled to present at the Citi 2011 Global Health Care Conference at 10:00 AM ET on March 2,...

TOPICS:

Seniors in Florida Report Problems Obtaining Needed Home Medical Equipment and Services Under Controversial Medicare Bidding System

February 25, 2011 7:34 am | by Bio-Medicine.Org | Comments

ORLANDO, Fla., Feb. 25, 2011 /PRNewswire-USNewswire/ -- Medicare beneficiaries are reporting problems receiving required home medical equipment and services in the wake of the January 1, 2011 implementation of Medicare's controversial "competitive" bidding program in Miami and Orlando,...

TOPICS:

The Smilow Comprehensive Prostate Cancer Center Installs Eigen ei-Nav|Artemisâ„¢

February 25, 2011 7:34 am | by Bio-Medicine.Org | Comments

GRASS VALLEY, Calif., Feb. 25, 2011 /- As a world leader in the advancement of the detection and treatment of prostate cancer, the Smilow Comprehensive Prostate Cancer Center ( www.smil o wprostatecancercenter.com ) at NYU Langone Medical Center is the first medical facility in the...

TOPICS:
Advertisement

Tenet 4Q profit soars as admissions drop slows

February 25, 2011 6:45 am | by The Associated Press | Comments

Hospital operator Tenet Healthcare Corp. said Friday its fourth-quarter earnings soared as revenue received a boost from patient volumes, and the company trimmed some expenses.The Dallas company earned $74 million, or 14 cents per share, in the three months that ended Dec. 31. That compares to...

Verenium CEO Riva retiring; CFO Levine taking helm

February 25, 2011 5:37 am | by Mass High Tech: The Journal of New England Technology | Comments

Verenium Corp., a maker of specialty enzymes, announced Friday that its president and CEO, Carlos Riva, will retire on March 31 and be succeeded by the company's chief financial officer James Levine.

Cigna declares annual dividend of 4 cents

February 25, 2011 4:45 am | by The Associated Press | Comments

Health insurer Cigna Corp., on Thursday, declared an annual dividend of 4 cents.The dividend is payable April 11 to shareholders of record as of March 11.Cigna also added $500 million to its share repurchase authorization. The company said it now has $675 million remaining on its stock buyback...

Accuray's General Counsel Wins Best Bay Area Corporate Counsel Award

February 25, 2011 4:37 am | by Bio-Medicine.Org | Comments

SUNNYVALE, Calif., Feb. 25, 2011 /- Accuray Incorporated (Nasdaq: ARAY ), a global leader in the field of radiosurgery, announced today that its Senior Vice President, General Counsel and Corporate Secretary, Darren Milliken , was named "Best General Counsel, Small Public Company" by the...

TOPICS:

Use of a Simple Three-Step Process and Prevention Algorithm to Protect Skin Shown to Reduce Pressure Ulcers

February 25, 2011 4:37 am | by Bio-Medicine.Org | Comments

SKILLMAN, N.J., Feb. 25, 2011 /- ConvaTec, a world-leading developer and marketer of innovative medical technologies for community and hospital care, today announced the introduction of a new national campaign to help reduce the risk of pressure ulcers in hospital and post-acute care...

TOPICS:

Cardiac device maker CardioFocus raises nearly $14M

February 25, 2011 4:35 am | by Mass High Tech: The Journal of New England Technology | Comments

CardioFocus Inc. of Marlborough, a maker of laser ablation treatments for atrial fibrillation, has raised $13.64 million of a planned $15.64 million equity round, the company reported in a regulatory filing.

TOPICS:

China Pharma Holdings, Inc. to Report Fiscal Year 2010 Financial Results on March 3, 2011

February 25, 2011 4:35 am | by Bio-Medicine.Org | Comments

HAIKOU, China, Feb. 25, 2011 /PRNewswire-Asia-FirstCall/ -- China Pharma Holdings, Inc. ("China Pharma") (NYSE Amex: CPHI ), which develops, manufactures, and markets specialty pharmaceutical products in China, today announced that it plans to release its fiscal year 2010 financial...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading